Early low-dose lenalidomide significantly reduces mutational burden without increasing AML risk in non-transfusion-dependent del(5q) MDS.

Researchers compared intensive chemotherapy with single-agent clofarabine in fit older adults with newly diagnosed AML.

On June 9, 2026, the New York State Department of Financial Services (“NYDFS” or the “Department”) announced a proposed regulation, Proposed New ...

Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue and cause ...

Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause ...

Recently updated change-of-control terms also fueled buyout chatter by outlining executive payouts and full equity ...

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an inflammatory ...

PRESS RELEASE AB SCIENCE REPORTS COMPLETION OF THE STEP 3 OF PHASE 1, EVALUATING THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA THE ...

Venetoclax plus pediatric-inspired chemotherapy yielded an 87% post-induction response in adult T-ALL, with 75% MRD negativity among complete remissions and strong activity in ETP-ALL. Cytopenias were ...

Warren Shen was diagnosed with acute myeloid leukemia after a physical revealed alarming blood test results ...